Financial reports
ARS
2023 FY
Annual report to shareholders
1 Apr 24
10-K
2023 FY
Annual report
27 Mar 24
10-Q
2023 Q3
Quarterly report
3 Nov 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
10-Q
2023 Q1
Quarterly report
3 May 23
ARS
2022 FY
Annual report to shareholders
21 Apr 23
10-K
2022 FY
Annual report
29 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
10-Q
2022 Q1
Quarterly report
28 Apr 22
Current reports
8-K
GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2023
27 Mar 24
8-K
Regulation FD Disclosure
1 Mar 24
8-K
Entry into a Material Definitive Agreement
2 Jan 24
8-K
GlycoMimetics Reports Highlights and Financial Results for Third Quarter 2023
3 Nov 23
8-K
GlycoMimetics Reports Highlights and Financial Results for Second Quarter 2023
2 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
22 May 23
8-K
GlycoMimetics Reports Highlights and Financial Results for First Quarter 2023
3 May 23
8-K
Entry into a Material Definitive Agreement
21 Apr 23
8-K
GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Year-end 2022
29 Mar 23
8-K
Regulation FD Disclosure
10 Mar 23
Registration and prospectus
S-8
Registration of securities for employees
27 Mar 24
S-8
Registration of securities for employees
29 Mar 23
424B5
Prospectus supplement for primary offering
28 Apr 22
S-3
Shelf registration
4 Mar 22
S-8
Registration of securities for employees
3 Mar 22
S-8
Registration of securities for employees
2 Mar 21
424B5
Prospectus supplement for primary offering
7 Oct 20
S-8
Registration of securities for employees
28 Feb 20
S-3
Shelf registration
17 May 19
S-8
Registration of securities for employees
7 Mar 19
Proxies
DEF 14A
Definitive proxy
1 Apr 24
PRE 14A
Preliminary proxy
22 Mar 24
DEF 14A
Definitive proxy
21 Apr 23
DEF 14A
Definitive proxy
11 Apr 22
DEF 14A
Definitive proxy
5 Apr 21
DEFA14A
Additional proxy soliciting materials
8 May 20
DEF 14A
Definitive proxy
16 Apr 20
DEF 14A
Definitive proxy
10 Apr 19
DEF 14A
Definitive proxy
13 Apr 18
DEF 14A
Definitive proxy
20 Apr 17
Other
EFFECT
Notice of effectiveness
25 Apr 22
CORRESP
Correspondence with SEC
20 Apr 22
UPLOAD
Letter from SEC
10 Mar 22
EFFECT
Notice of effectiveness
30 May 19
CORRESP
Correspondence with SEC
23 May 19
UPLOAD
Letter from SEC
23 May 19
EFFECT
Notice of effectiveness
6 Oct 17
CORRESP
Correspondence with SEC
5 Oct 17
UPLOAD
Letter from SEC
5 Oct 17
EFFECT
Notice of effectiveness
24 Mar 15
Ownership
4
DANIEL M JUNIUS
2 Apr 24
4
Rachel K. King
2 Apr 24
4
Mark Alan Goldberg
2 Apr 24
SC 13D/A
NEW ENTERPRISE ASSOCIATES 10 L P
29 Feb 24
SC 13D/A
NEW ENTERPRISE ASSOCIATES 10 L P
12 Feb 24
SC 13G/A
Artal International S.C.A.
9 Feb 24
SC 13G/A
BIOTECHNOLOGY VALUE FUND L P
29 Jan 24
4
Bruce S Johnson
17 Jan 24
4
Harout Semerjian
17 Jan 24
4
Edwin Rock
17 Jan 24